menu
    • menu

    Company profile for MoonLake Immunotherapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody®1 technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.MoonLake has a portfolio of therapeutic programs based on the phase 3-ready Nanobody® Sonelokimab (SLK, M1095/ALX-0761), a biologic molecule potentially capable of driving disease modification in der...
    MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody®1 technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.MoonLake has a portfolio of therapeutic programs based on the phase 3-ready Nanobody® Sonelokimab (SLK, M1095/ALX-0761), a biologic molecule potentially capable of driving disease modification in dermatology and rheumatology patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MoonLake ImmunotherapeuticsSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Untermüli 7 / Postfach 7444 6302 Zug
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://moonlaketx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/moonlake-immunotherapeutics-ag/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Moonlake Immunotherapeutics Prices $75M Offering
    Moonlake Immunotherapeutics Prices $75M Offering

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181328/0/en/MoonLake-Immunotherapeutics-Announces-Pricing-of-75-Million-Underwritten-Offering.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Moonlake Immunotherapeutics Unveils Q3 2025 Financials Update
    Moonlake Immunotherapeutics Unveils Q3 2025 Financials Update

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181261/0/en/MoonLake-Immunotherapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Announces-New-Data-from-Clinical-Trials-of-its-Nanobody-Sonelokimab.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Robbins Geller Alerts MLTX Investors on Class Action
    Robbins Geller Alerts MLTX Investors on Class Action

    17 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-17/mltx-investor-alert-robbins-geller-rudman-dowd-llp-announces-that-moonlake-immunotherapeutics-inv

    PHARMIWEB
    17 Oct 2025
    Share Share
    MoonLake's Stock Crashes After Eclipses Il-17 Drug's Phase 3
    MoonLake's Stock Crashes After Eclipses Il-17 Drug's Phase 3

    30 Sep 2025

    // PRESS RELEASE

    https://ir.moonlaketx.com/news-releases/news-release-details/moonlake-immunotherapeutics-reports-week-16-results-vela-phase-3

    PRESS RELEASE
    30 Sep 2025
    Share Share
    Moon Lake Immunotherapeutics Reports Q2 2025 Results and Updates
    Moon Lake Immunotherapeutics Reports Q2 2025 Results and Updates

    05 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/05/3127175/0/en/MoonLake-Immunotherapeutics-Reports-Second-Quarter-2025-Financial-Results-and-Provides-a-Business-Update.html

    GLOBENEWSWIRE
    05 Aug 2025
    Share Share
    Merck made $3B offer for MoonLake & could revive interest
    Merck made $3B offer for MoonLake & could revive interest

    04 Jun 2025

    // FINANCIALTIMES

    https://www.ft.com/content/5899ea69-e5fe-49f1-8ada-79f26c9254d8

    FINANCIALTIMES
    04 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search